In 2023, Italy led European business expenditure in R&D for irradiation, electromedical, and electrotherapeutic equipment manufacturing with 185.84 million euros, growing 11.14% year-on-year. Finland and Belgium followed at 103.4 million and 96.71 million euros, with 1.08% and 9.02% growth respectively. Spain's expenditure stood at 11.82 million euros, while the Czech Republic, Poland, and Portugal saw growth rates of 13.23%, 10.44%, and 18.86% respectively, even with lower absolute values. Serbia reported negligible growth and expenditure.
Future trends to watch include technology evolution in medical devices, potential shifts due to regulatory changes, and increased collaboration between countries to boost innovation across Europe. Monitoring these dynamics could uncover new opportunities or risks in R&D investment.
Top countries in Business Expenditure on R&D in Irradiation, Electromedical and Electrotherapeutic Equipment Manufacturing by Country
| # | 8 Countries | Million Euros | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Italy | 185.84 | 2023 | +4.9% | +11.14% | View data |
| 2 | 2 Finland | 103.4 | 2023 | +11.28% | +1.08% | View data |
| 3 | 3 Belgium | 96.71 | 2023 | +6.45% | +9.02% | View data |
| 4 | 4 Spain | 11.82 | 2021 | View data | ||
| 5 | 5 Czech Republic | 9.05 | 2023 | +5.66% | +13.23% | View data |
| 6 | 6 Poland | 8.13 | 2023 | +10.56% | +10.44% | View data |
| 7 | 7 Portugal | 1.12 | 2023 | +4.86% | +18.86% | View data |
| 8 | 8 Serbia | 0.021 | 2023 | +16.67% | View data |
